Pulse Biosciences Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
116
- Stock Symbol
-
PLSE
- Share Price
-
$46.38
- (As of Monday Closing)
Pulse Biosciences General Information
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Contact Information
Website
www.pulsebiosciences.comCorporate Office
- 3957 Point Eden Way
- Hayward, CA 94545
- United States
Corporate Office
- 3957 Point Eden Way
- Hayward, CA 94545
- United States
Pulse Biosciences Stock Performance
As of 16-Nov-2026, Pulse Biosciences’s stock price is $46.38. Its current market cap is $3.41B with 73.5M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $46.38 | $50.44 | $12.56 - $58.94 | $3.41B | 73.5M | 503K | -$1.21 |
Pulse Biosciences Financials Summary
As of 30-Sep-2026, Pulse Biosciences has a trailing 12-month revenue of $1.49M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,465,577 | 843,125 | 1,000,339 | 633,184 |
| Revenue | 1,494 | 350 | 0 | 0 |
| EBITDA | (85,916) | (75,920) | (55,097) | (42,367) |
| Net Income | (83,722) | (72,781) | (53,585) | (42,210) |
| Total Assets | 201,584 | 94,539 | 132,460 | 59,154 |
| Total Debt | 6,363 | 7,530 | 8,898 | 9,144 |
Pulse Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pulse Biosciences Comparisons
Industry
Financing
Details
Pulse Biosciences Competitors (7)
One of Pulse Biosciences’s 7 competitors is RefleXion, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RefleXion | Venture Capital-Backed | Hayward, CA | ||||
| Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
| CardioFocus | Venture Capital-Backed | Marlborough, MA | ||||
| Edwards Lifesciences | Corporation | Irvine, CA | ||||
| ViewRay | Formerly VC-backed | Bedford, OH |
Pulse Biosciences Patents
Pulse Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026165183-A1 | Clamp-type electrode apparatuses and methods | Pending | 31-Jan-2025 | ||
| WO-2026156323-A1 | Isolation interface apparatuses and methods for high-voltage medical treatment | Pending | 16-Jan-2025 | ||
| WO-2026117365-A1 | Electrical applicator apparatuses and methods of use | Pending | 26-Nov-2024 | ||
| WO-2026030164-A1 | Conductive spacer in an electrode assembly of an electrical treatment apparatus | Pending | 29-Jul-2024 | ||
| WO-2026015310-A1 | Clamp electrodes forming gripping surfaces | Pending | 08-Jul-2024 | A61B18/1445 |
Pulse Biosciences Signals
Pulse Biosciences ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
36.26 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Pulse Biosciences FAQs
-
When was Pulse Biosciences founded?
Pulse Biosciences was founded in 2014.
-
Where is Pulse Biosciences headquartered?
Pulse Biosciences is headquartered in Hayward, CA.
-
What is the size of Pulse Biosciences?
Pulse Biosciences has 116 total employees.
-
What industry is Pulse Biosciences in?
Pulse Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Pulse Biosciences a private or public company?
Pulse Biosciences is a Public company.
-
What is Pulse Biosciences’s stock symbol?
The ticker symbol for Pulse Biosciences is PLSE.
-
What is the current stock price of Pulse Biosciences?
As of 16-Nov-2026 the stock price of Pulse Biosciences is $46.38.
-
What is the current market cap of Pulse Biosciences?
The current market capitalization of Pulse Biosciences is $3.41B.
-
What is Pulse Biosciences’s current revenue?
The trailing twelve month revenue for Pulse Biosciences is $1.49M.
-
Who are Pulse Biosciences’s competitors?
RefleXion, Abiomed, CardioFocus, Edwards Lifesciences, and ViewRay are some of the 7 competitors of Pulse Biosciences.
-
What is Pulse Biosciences’s annual earnings per share (EPS)?
Pulse Biosciences’s EPS for 12 months was -$1.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process